Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-24 @ 5:47 PM
NCT ID:
NCT01660568
Brief Summary:
We retrospectively review patients with refractory or relapsed ENKL who received a gemcitabine-containing regimen
Study:
NCT01660568
Study Brief:
Protocol Section:
NCT01660568